The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2020
Filed:
Jun. 19, 2019
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Huji Turdi, Yardley, PA (US);
Jon J. Hangeland, Morrisville, PA (US);
R. Michael Lawrence, Yardley, PA (US);
Saleem Ahmad, Wall, NJ (US);
Wei Meng, Pennington, NJ (US);
Robert Paul Brigance, Levittown, PA (US);
Pratik Devasthale, Plainsboro, NJ (US);
Guohua Zhao, Princeton, NJ (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/438 (2006.01); A61K 31/675 (2006.01); C07D 211/90 (2006.01); A61K 31/4418 (2006.01); C07D 401/04 (2006.01); A61K 31/4439 (2006.01); C07D 413/04 (2006.01); C07D 221/20 (2006.01); C07D 413/14 (2006.01); A61K 31/5377 (2006.01); C07D 401/14 (2006.01); A61K 45/06 (2006.01); C07F 9/59 (2006.01); C07F 9/40 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 407/14 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 211/86 (2006.01); C07F 9/535 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/438 (2013.01); A61K 31/4418 (2013.01); A61K 31/4439 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); C07D 211/86 (2013.01); C07D 211/90 (2013.01); C07D 221/20 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/14 (2013.01); C07D 407/14 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07F 9/4006 (2013.01); C07F 9/5352 (2013.01); C07F 9/59 (2013.01);
Abstract
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.